Group Calls on Ottawa to Puff $25m into Medical Marijuana Research
A group comprised of doctors, patients, health charities and scientists is urging Ottawa to invest $25 million over the next five years for research into the health effects and potential therapeutic benefits of medical marijuana.
In a report released Wednesday, the Medical Cannabis Research Roundtable highlighted the lack of reliable, peer-reviewed Canadian-based research into marijuana as a potential treatment for a variety of diseases and conditions.
"As our country embarks on a debate about the legalization of recreational marijuana, we should not lose sight of the need to invest in medical science and proper trials to better understand the impacts and effects of medical cannabis," roundtable chairman Dr. Jason McDougall, a professor of pharmacology and anesthesia at Dalhousie University in Halifax, said in a statement.
"Physicians and patients are left with uncertainty about the potential therapeutic benefits of medical cannabis and particularly the potential to bring relief to those living...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin